TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive DCT To Renegotiate Cooperative Groups Term Of Award, Considering Other Major Changes March 4, 1988
TCL Archive FDA, NCI united in pursuit of 2015 goal, Andrew von Eschenbach tells cancer center directors; says his appointment was necessary to “maintain the momentum of the FDA.” October 21, 2005
